Patents by Inventor Seyed Mahdi Rezayat Sorkhabadi

Seyed Mahdi Rezayat Sorkhabadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10485895
    Abstract: A mixture for an injectable scaffold may include a self-assembling core and an additive. The additive may include an angiogenic agent, a small molecule drug, and/or an anti-inflammatory agent. The scaffold can be applied to sites where bone growth is desired.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: November 26, 2019
    Assignees: CELLULAR AND MOLECULAR RESEARCH CENTER, IRAN UNIVERSITY OF MEDICAL SCIENCES
    Inventors: Shima Tavakol, Behnaz Tavakol, Amin Almasi, Seyed Mahdi Rezayat Sorkhabadi
  • Patent number: 10428111
    Abstract: A molecule comprising a lipid, a peptide and a linker to bind the lipid to the peptide which have specific amino acid sequence to bind to Epidermal Growth Factor Receptor (EGFR) of tumor cells, and a liposomal composition which is targeted by the molecule, and method for preparing thereof is disclosed.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: October 1, 2019
    Inventors: Mahmoud Reza Jaafari, Masoumeh Zahmatkeshan, Seyed Mahdi Rezayat Sorkhabadi
  • Patent number: 10123973
    Abstract: Disclosed is a liposomal composition for treatment of cancer, which includes at least one PEG-Phospholipid conjugated molecule, cholesterol, and at least one phospholipid.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: November 13, 2018
    Assignees: MASHHAD UNIVERSITY OF MEDICAL SCIENCE, TEHRAN UNIVERSITY OF MEDICAL SCIENCE
    Inventors: Mahmoud Reza Jaafari, Fatemeh Gheybi, Seyed Mahdi Rezayat Sorkhabadi
  • Publication number: 20170290951
    Abstract: A mixture for an injectable scaffold may include a self-assembling core and an additive. The additive may include an angiogenic agent, a small molecule drug, and/or an anti-inflammatory agent. The scaffold can be applied to sites where bone growth is desired.
    Type: Application
    Filed: June 26, 2017
    Publication date: October 12, 2017
    Inventors: Shima Tavakol, Behnaz Tavakol, Amin Almasi, Seyed Mahdi Rezayat Sorkhabadi
  • Publication number: 20170183380
    Abstract: A molecule comprising a lipid, a peptide and a linker to bind the lipid to the peptide which have specific amino acid sequence to bind to Epidermal Growth Factor Receptor (EGFR) of tumor cells, and a liposomal composition which is targeted by the molecule, and method for preparing thereof is disclosed.
    Type: Application
    Filed: July 28, 2016
    Publication date: June 29, 2017
    Inventors: Mahmoud Reza Jaafari, Masoumeh Zahmatkeshan, Seyed Mahdi Rezayat Sorkhabadi
  • Publication number: 20170172921
    Abstract: A method for preparing a liposome composition for delivering polyphenolic compounds to the target organs may include preparing a complex that contains at least one polyphenolic compound. Then, encapsulating the polyphenolic compound into a liposome composition by admixing the prepared complex with the liposome ingredients.
    Type: Application
    Filed: December 14, 2016
    Publication date: June 22, 2017
    Inventors: Mahmoud Reza Jaafari, Fatemeh Gheybi, Seyed Mahdi Rezayat Sorkhabadi
  • Publication number: 20160228365
    Abstract: Disclosed is a liposomal composition for treatment of cancer, which includes at least one PEG-Phospholipid conjugated molecule, cholesterol, and at least one phospholipid.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Inventors: Mahmoud Reza Jaafari, Fatemeh Gheybi, Seyed Mahdi Rezayat Sorkhabadi